The Valley Desk

NCT01780545 · Interventional trial

Phase 2 Study of Docetaxel +/- OGX-427 in Patients With Relapsed or Refractory Metastatic Bladder Cancer

Overall registry status Completed

Phase 2

Conditions Bladder Cancer, Urothelial Carcinoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov